OBJECTIVE: To examine the effect of providing a financial incentive to authors of randomized clinical trials (RCTs) to obtain individual patient data (IPD). STUDY DESIGN AND SETTING: Parallel-group RCT with authors identified in the RCTs eligible for two systematic reviews. The authors were randomly allocated to the intervention (financial incentive with several contact approaches) or control group (using the same contact approaches). Studied outcomes: proportion of authors who provided IPD, time to obtain IPD, and completeness of IPD received. RESULTS: Of the 129 authors contacted, 37 authors suggested or contacted a person/funder providing relevant details or showed interest to collaborate, while 45 authors directed us to contact a person...
An increasing prevalence of data-sharing models, aimed at making individual participant data (IPD) f...
AbstractObjectivesEvaluate current data sharing activities of UK publicly funded Clinical Trial Unit...
International audienceObjectives: To explore the effectiveness of data sharing by randomized control...
BACKGROUND: Individual patient data (IPD) meta-analysis is considered the "gold standard" for explor...
Background Individual patient data (IPD) meta-analysis is considered the “gold standard” for explori...
ObjectivesMeta-analysis based on individual patient data (IPD) from randomised trials is superior to...
BACKGROUND: Individual participant data (IPD) from completed clinical trials should be responsibly s...
International audienceOBJECTIVES: To explore the impact of data-sharing initiatives on the intent to...
Objectives To explore the effectiveness of data sharing by randomized controlled trials (RCTs) in jo...
BACKGROUND: Building a dataset of individual participant data (IPD) for meta-analysis represents con...
BackgroundShifts in data sharing policy have increased researchers’ access to individual participant...
An increasing prevalence of data-sharing models, aimed at making individual participant data (IPD) f...
BackgroundBuilding a dataset of individual participant data (IPD) for meta-analysis represents consi...
<div><p>Background</p><p>Calls have been made for increased access to individual participant data (I...
An increasing prevalence of data-sharing models, aimed at making individual participant data (IPD) f...
AbstractObjectivesEvaluate current data sharing activities of UK publicly funded Clinical Trial Unit...
International audienceObjectives: To explore the effectiveness of data sharing by randomized control...
BACKGROUND: Individual patient data (IPD) meta-analysis is considered the "gold standard" for explor...
Background Individual patient data (IPD) meta-analysis is considered the “gold standard” for explori...
ObjectivesMeta-analysis based on individual patient data (IPD) from randomised trials is superior to...
BACKGROUND: Individual participant data (IPD) from completed clinical trials should be responsibly s...
International audienceOBJECTIVES: To explore the impact of data-sharing initiatives on the intent to...
Objectives To explore the effectiveness of data sharing by randomized controlled trials (RCTs) in jo...
BACKGROUND: Building a dataset of individual participant data (IPD) for meta-analysis represents con...
BackgroundShifts in data sharing policy have increased researchers’ access to individual participant...
An increasing prevalence of data-sharing models, aimed at making individual participant data (IPD) f...
BackgroundBuilding a dataset of individual participant data (IPD) for meta-analysis represents consi...
<div><p>Background</p><p>Calls have been made for increased access to individual participant data (I...
An increasing prevalence of data-sharing models, aimed at making individual participant data (IPD) f...
AbstractObjectivesEvaluate current data sharing activities of UK publicly funded Clinical Trial Unit...
International audienceObjectives: To explore the effectiveness of data sharing by randomized control...